Regulatory Briefs: U.K. Trials Database; Hospitals Seek UDI Rule; FDA Workshops
This article was originally published in The Gray Sheet
Executive Summary
The U.K.’s National Health Service is requiring all U.K. trials to be registered in a clinical trial database. Five influential hospital systems urge the White House to release the UDI final rule. FDA schedules metabolic disease workshop. More regulatory news.
You may also be interested in...
$18.4 Million In User Fees Left In CDRH’s Coffers, How Long Will It Last?
The device center says it had $18.4 million in user fees remaining as of Oct. 1 to continue its work focused solely on user-fee funded activities, but the agency is unsure how long the funds will last if the government shutdown continues.
FDA Issues UDI Final Rule, Removes Direct Marking Requirement For Implants
The long-awaited unique device identifier final rule is intended to help FDA, device companies and health care providers track medical devices. The rule addresses many of industry’s concerns with FDA’s initial proposal and was met with general support by companies.
Regulatory Briefs: OMB Updates On UDI, eMDR Rule; Circ Panel Scheduled
Hospital groups meet with OMB on UDI rule. Electronic Medical Device Reporting final rule reaches OMB. More regulatory news.